Number of Clinical Trials 2015
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
- #1
United States
- #2
France
- #3
Germany
- #4
Canada
- #5
United Kingdom
- #6
China
- #7
South Korea
- #8
Denmark
- #9
Spain
- #10
Italy
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #128
Paraguay
- #127
Myanmar
- #126
Montenegro
- #125
Mauritius
- #124
Madagascar
- #123
Lesotho
- #122
Kuwait
- #121
Jamaica
- #120
Iraq
- #119
Georgia
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Algeria
In 2015, Algeria ranked #88 globally with a total of 2 clinical trials. This figure is notably lower than many of its North African neighbors, reflecting a regional trend where countries like Tunisia and Morocco have more active clinical research environments. Limited investment in healthcare infrastructure and a relatively small pharmaceutical industry hinder the growth of clinical trials in Algeria, impacting its capacity for medical research and innovation.
Austria
In 2015, Austria ranked #22 globally with a total of 107 clinical trials. This figure is notable when compared to neighboring countries like Hungary, which had significantly fewer trials, indicating Austria's strong position in clinical research within Central Europe. Contributing factors include Austria's well-developed healthcare infrastructure, robust regulatory environment, and a high level of investment in medical research, which attract both domestic and international pharmaceutical companies.
Estonia
In 2015, Estonia ranked #115 globally with a total of 1 clinical trial. This figure is significantly lower than many neighboring countries, highlighting a limited clinical research environment compared to the regional average. Contributing factors include Estonia's small population and relatively underdeveloped healthcare infrastructure, which may hinder the scale and scope of clinical research initiatives.
Colombia
In 2015, Colombia ranked #50 globally with a total of 13 clinical trials. This figure is notably lower than the global average, reflecting a more limited capacity for clinical research compared to regional leaders like Brazil. Contributing factors include Colombia's developing healthcare infrastructure and a growing emphasis on improving regulatory frameworks, which aim to enhance the environment for clinical research and attract international partnerships.
United Kingdom
The United Kingdom ranked #5 globally with a total of 526 clinical trials in 2015. This figure highlights the UK's prominence in clinical research, significantly higher than many of its European neighbors. Key drivers include a robust healthcare system, strong academic institutions, and government support for medical research, positioning the UK as a leader in innovative healthcare solutions.
Croatia
In 2015, Croatia ranked #62 globally with a total of 7 clinical trials. This places Croatia below many of its European neighbors, reflecting a smaller scale of clinical research activity compared to countries like Germany, which leads in this area. Factors contributing to this relatively low number include a smaller population and limited investment in research and development, which can hinder the growth of clinical trial initiatives.
South Africa
In 2015, South Africa ranked #32 globally with a total of 41 clinical trials. This figure is notable when compared to other African nations, reflecting South Africa's relatively advanced research infrastructure in the region. Contributing factors include a robust healthcare system, a diverse population that facilitates various clinical studies, and supportive government policies aimed at promoting medical research and innovation.
Mongolia
Mongolia ranked #102 globally with 2 clinical trials in 2015. This number is notably low compared to the global average, reflecting the country's limited research infrastructure and funding in the healthcare sector. The sparse population and vast geographic expanse of Mongolia contribute to challenges in conducting clinical trials, as well as a need for improved regulatory frameworks to foster research initiatives.
Philippines
In 2015, the Philippines ranked #58 globally with a total of 10 clinical trials. This figure is relatively low compared to regional leaders like India, which is known for its robust clinical research environment. Contributing factors to the Philippines' position include its developing healthcare infrastructure and regulatory environment, which can impact the attractiveness for international clinical research sponsors.
Australia
In 2015, Australia ranked #24 globally with a total of 91 clinical trials. This figure is significantly below the leading countries, such as the United States, which dominates the clinical trial landscape. Australia's robust healthcare system, coupled with a strong emphasis on medical research and development, supports its clinical trial activities, driven by both government funding and a collaborative environment among research institutions.
Analysis & Context
In 2015, the United States led the world in the Number of Clinical Trials with a total of 5,347, while the global range spanned from a minimum of 1 to this maximum value. The global average for the Number of Clinical Trials conducted across 128 countries was 100.36, providing a broad context for medical research activity worldwide.
Leading Nations in Clinical Trials
The dominance of the United States in clinical trials is notable, with the country conducting more than six times the number in France, the second-highest country at 808 trials. This disparity highlights the significant resources and infrastructure dedicated to medical research in the U.S. Factors such as a robust pharmaceutical industry, extensive research facilities, and a large patient population contribute to this leadership position.
Other countries with substantial clinical trial activity include Germany with 577 trials and Canada with 575. These nations benefit from strong healthcare systems, supportive regulatory frameworks, and active collaboration between public and private sectors, which together foster an environment conducive to medical research and innovation.
Minimal Participation and Its Implications
At the opposite end of the spectrum, several countries, including Mauritius, Cyprus, and Azerbaijan, reported only 1 clinical trial each. The limited number of trials in these regions can be attributed to smaller populations, less developed healthcare infrastructure, and limited financial investment in research. The lack of clinical trials in these countries suggests potential challenges in accessing cutting-edge treatments and innovations, which could impact the quality of healthcare available.
Year-over-Year Changes in Clinical Trial Activity
The analysis of year-over-year changes reveals significant increases in some countries, such as France with a rise of 178 trials (28.3%) and the United States with an increase of 154 trials (3.0%). These surges might be linked to policy changes, increased funding for research, or strategic priorities in healthcare innovation.
Conversely, South Korea experienced a decrease of 25 trials (-5.4%), and Netherlands saw a reduction of 24 trials (-10.3%). Such declines could stem from regulatory challenges, shifts in research focus, or economic constraints affecting the ability to sustain previous levels of clinical trial activity.
Impacts of Economic and Policy Factors
Economic and policy factors play a crucial role in shaping the landscape of clinical trials. Countries with high numbers of trials, such as United States, France, and Germany, typically have strong economic foundations and supportive government policies that promote research and development. These nations often prioritize healthcare innovation as a means to boost national health outcomes and economic growth.
In contrast, countries with minimal trial activity may face economic limitations that restrict investment in research infrastructure. Additionally, regulatory environments that are less conducive to clinical research can hinder the initiation and completion of trials, limiting opportunities for local scientific advancement and access to new treatments.
Overall, the distribution of clinical trials in 2015 underscores the importance of economic strength, policy support, and infrastructure in fostering medical research. As countries continue to navigate these factors, the global landscape of clinical trials will likely evolve, impacting the availability and development of new medical treatments worldwide.
Frequently Asked Questions About Number of Clinical Trials in 2015
Which country conducted the most clinical trials in 2015?
The United States conducted the most clinical trials in 2015, with a total of 5,347 trials.
What was the average number of clinical trials conducted per country in 2015?
The average number of clinical trials conducted per country in 2015 was 100.
Which country conducted the fewest clinical trials in 2015?
Mauritius conducted the fewest clinical trials in 2015, with only 1 trial.
What was the median number of clinical trials conducted by countries in 2015?
The median number of clinical trials conducted by countries in 2015 was 7.
How many countries conducted only 1 clinical trial in 2015?
Ten countries conducted only 1 clinical trial in 2015, including Mauritius, Cyprus, and Azerbaijan.
What is the range of clinical trials conducted between the highest and lowest countries in 2015?
The range of clinical trials conducted between the highest and lowest countries in 2015 is from 5,347 trials in the United States to 1 trial in Mauritius.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2015. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2015
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.